EFFECTIVENESS OF A DAPSONE COMPLIANCE PROGRAM IN LEPROSY

STEPHEN C. PISCITELLI, LARRY H. DANZIGER, CARLOTTA HILL, ARLENE A. SLAJCHERT, DENNIS P. WEST, JAMES H. FISCHER*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background. Long‐term effectiveness of a dapsone compliance program was assessed in patients with leprosy. Methods. The monitoring program consists of urine dap‐sone/creatinine ratio determination at each visit with subsequent patient feedback and education. Eighty‐eight patients receiving dapsone and seen in a leprosy clinic from 1985–1990 were included. Results. The proportion of patients compliant with dapsone during a given year ranged from 70.0% (1987) to 94.4% (1989). Overall compliance for the 6‐year period was 81.6%. This level of compliance was significantly different (P < 0.05) than the baseline compliance in the leprosy clinic of 46.7%. Conclusions. Compliance monitoring, combined with active patient involvement, was effective in sustaining high compliance over a 6‐year period.

Original languageEnglish (US)
Pages (from-to)206-209
Number of pages4
JournalInternational Journal of Dermatology
Volume32
Issue number3
DOIs
StatePublished - Mar 1993

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'EFFECTIVENESS OF A DAPSONE COMPLIANCE PROGRAM IN LEPROSY'. Together they form a unique fingerprint.

Cite this